Riskpilot← Back to searchSign inGet full accessØYELEGEKLINIKKEN AS
ASActiveOrg 913488458Fjordgata 82, 7010 TrondheimMedical specialists activities · NACE 8622Est. 20145 employees
Revenue 2025
NOK 17,1M
+24% vs 2024
EBITDA margin
50.1%
+36% vs 2024
Equity ratio
0.9%
Financial strength
Net profit 2025
NOK 6,5M
+38% vs 2024
| Revenue | NOK 17,1M | +24% |
| EBITDA | NOK 8,6M | +36% |
| Net profit | NOK 6,5M | +38% |
| Total assets | NOK 12,4M | +23% |
| Equity | NOK 115K | -93% |
| Employees | 5 | — |
Legal name
ØYELEGEKLINIKKEN AS
Org number
913488458
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
11. april 2014
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av helsetjeneste, salg, forskning, informasjon og konsulentvirksomhet, investering og utleie, samt hva hermed står i forbindelse, herunder å delta i andre selskap med liknende virksomhet.
Address
Fjordgata 82, 7010 Trondheim
Phone
+4773514880
Email
post@oyelegeklinikken.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 872 | 12 883 | 13 574 | 13 877 | 17 144 |
| Staff expenses | −2 762 | −2 822 | −3 687 | −4 121 | −4 351 |
| EBITDA | 4 609 | 5 937 | 5 782 | 6 327 | 8 596 |
| Depreciation & amort. | −196 | −301 | −257 | −254 | −163 |
| EBIT | 4 413 | 5 636 | 5 525 | 6 074 | 8 433 |
| Net financials | −11 | −30 | −14 | −19 | −58 |
| Profit before tax | 4 402 | 5 606 | 5 511 | 6 054 | 8 375 |
| Tax | 968 | 1 233 | 1 213 | 1 332 | 1 842 |
| Net profit | 3 434 | 4 372 | 4 299 | 4 723 | 6 532 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 688 | 7 215 | 8 871 | 10 106 | 12 390 |
| Equity | 45 | 1 918 | 1 436 | 1 598 | 115 |
| Long-term debt | 755 | 721 | 678 | 617 | 549 |
| Short-term debt | 1 887 | 4 576 | 6 757 | 7 890 | 11 727 |
| Total debt | 2 642 | 5 297 | 7 435 | 8 507 | 12 276 |
EBITDA margin
50.1%
This company
15.8%
Market median
+217% vs market
20212025
Equity ratio
0.9%
This company
38.2%
Market median
-98% vs market
20212025
Return on equity
5690.1%
This company
18.4%
Market median
+30824% vs market
20212025
Net profit margin
38.1%
This company
8.1%
Market median
+370% vs market
20212025
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20212025
Debt / equity
106.93×
This company
0.62×
Market median
-17147% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HF Chief Executive Officer | Chief Executive Officer | 2014 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Harmonium Invest As
ØYELEGEKLINIKKEN AS Board members of ØYELEGEKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Harald Fredrik Hodne Ulltveit-Moe | Chief Executive Officer | 0 companies |
| Marit Braute | Board of Directors | 0 companies |